[Streptococcus pyogenes an emerging pathogen].
Cohen
R
R
Aujard
Y
Y
Bidet
P
P
Bourrillon
A
A
Bingen
E
E
Foucaud
P
P
François
M
M
Garnier
J M
JM
Gendrel
D
D
Guillot
M
M
Hau
I
I
Olivier
C
C
Quinet
B
B
Raymond
J
J
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002981:Clindamycin / Q000627:therapeutic use; D004351:Drug Resistance / Q000235:genetics; D006801:Humans; D018942:Macrolides / Q000627:therapeutic use; D013290:Streptococcal Infections / Q000175:diagnosis* / Q000188:drug therapy* / Q000382:microbiology / Q000503:physiopathology; D013297:Streptococcus pyogenes / Q000187:drug effects / Q000235:genetics / Q000472:pathogenicity*; D047090:beta-Lactams / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D018942:Macrolides; D047090:beta-Lactams; D002981:Clindamycin